SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-011363
Filing Date
2021-05-28
Accepted
2021-05-28 16:31:36
Documents
12
Period of Report
2021-05-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20210525.htm   iXBRL 8-K 62668
  Complete submission text file 0001628280-21-011363.txt   201217

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20210525.xsd EX-101.SCH 1953
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20210525_lab.xml EX-101.LAB 24270
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20210525_pre.xml EX-101.PRE 12683
5 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20210525_htm.xml XML 11250
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 21980794
SIC: 2836 Biological Products, (No Diagnostic Substances)